Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$1.27
-1.6%
$0.93
$0.53
$1.90
$98.84M1.061.44 million shs292,640 shs
icad inc. stock logo
ICAD
icad
$3.87
$3.82
$1.19
$4.02
$106.31M1.37426,282 shsN/A
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
$0.99
-2.6%
$1.11
$0.73
$1.80
$107.80M1.21984,431 shs758,115 shs
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
$0.00
$1.61
$2.69
$32.98M0.419,793 shs113,500 shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-7.19%-0.77%+40.20%+107.30%+21.70%
icad inc. stock logo
ICAD
icad
0.00%0.00%0.00%-2.27%+130.36%
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
0.00%+2.22%-8.93%-21.54%+22.16%
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Hyperfine, Inc. stock logo
HYPR
Hyperfine
1.5259 of 5 stars
1.35.00.00.02.51.70.6
icad inc. stock logo
ICAD
icad
N/AN/AN/AN/AN/AN/AN/AN/A
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
1.8003 of 5 stars
3.51.00.00.01.11.70.6
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hyperfine, Inc. stock logo
HYPR
Hyperfine
2.67
Moderate Buy$1.281.05% Upside
icad inc. stock logo
ICAD
icad
2.00
HoldN/AN/A
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
3.00
Buy$3.55257.25% Upside
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest PEYE, HYPR, LUCD, and ICAD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/15/2025
Hyperfine, Inc. stock logo
HYPR
Hyperfine
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$0.68 ➝ $0.85
8/14/2025
Hyperfine, Inc. stock logo
HYPR
Hyperfine
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$1.50 ➝ $2.00
8/13/2025
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$3.00
7/16/2025
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$3.00
6/6/2025
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$7.50 ➝ $7.75
6/3/2025
Hyperfine, Inc. stock logo
HYPR
Hyperfine
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
(Data available from 8/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$12.89M7.67N/AN/A$0.67 per share1.90
icad inc. stock logo
ICAD
icad
$19.61M5.42N/AN/A$1.08 per share3.58
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
$4.35M24.78N/AN/A($0.78) per share-1.27
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
$15.68M0.00N/AN/A$0.53 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$40.72M-$0.52N/AN/AN/A-364.54%-84.82%-69.39%N/A
icad inc. stock logo
ICAD
icad
-$5.62M-$0.19N/AN/A-26.63%-15.03%-11.77%N/A
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
-$45.53M-$1.19N/AN/AN/A-1,476.35%N/A-120.43%N/A
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
-$930K-$0.06N/AN/AN/A-5.93%-12.10%-6.41%N/A

Latest PEYE, HYPR, LUCD, and ICAD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$0.12-$0.12N/A-$0.12$3.00 million$2.70 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Hyperfine, Inc. stock logo
HYPR
Hyperfine
N/AN/AN/AN/AN/A
icad inc. stock logo
ICAD
icad
N/AN/AN/AN/AN/A
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
N/AN/AN/AN/AN/A
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hyperfine, Inc. stock logo
HYPR
Hyperfine
N/A
5.02
4.41
icad inc. stock logo
ICAD
icad
N/A
3.66
3.57
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
N/A
1.15
1.13
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
0.23
1.42
0.76

Institutional Ownership

CompanyInstitutional Ownership
Hyperfine, Inc. stock logo
HYPR
Hyperfine
15.03%
icad inc. stock logo
ICAD
icad
24.61%
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
74.01%
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
N/A

Insider Ownership

CompanyInsider Ownership
Hyperfine, Inc. stock logo
HYPR
Hyperfine
30.98%
icad inc. stock logo
ICAD
icad
10.29%
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
6.80%
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
22.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Hyperfine, Inc. stock logo
HYPR
Hyperfine
19077.83 million53.72 millionOptionable
icad inc. stock logo
ICAD
icad
14027.47 million24.64 millionOptionable
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
70108.48 million101.10 millionNo Data
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
8016.92 million13.08 millionNot Optionable

Recent News About These Companies

German Precision Optics Passion ED 8x42 Binocular
Tag: LaCroix Precision Optics
Q3 2025 Precision Optics Corporation Inc Earnings Call
Precision Optics appoints Joseph Pellegrino to board of directors
Q2 2025 Precision Optics Corporation Inc Earnings Call
Precision Optics launches endoscopic platform

New MarketBeat Followers Over Time

Media Sentiment Over Time

Hyperfine stock logo

Hyperfine NASDAQ:HYPR

$1.27 -0.02 (-1.55%)
Closing price 04:00 PM Eastern
Extended Trading
$1.26 -0.01 (-0.71%)
As of 06:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

icad stock logo

icad NASDAQ:ICAD

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

Lucid Diagnostics stock logo

Lucid Diagnostics NASDAQ:LUCD

$0.99 -0.03 (-2.58%)
Closing price 04:00 PM Eastern
Extended Trading
$1.00 +0.01 (+1.14%)
As of 07:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.

Precision Optics stock logo

Precision Optics OTCMKTS:PEYE

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.